Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2848-2853

  Caulin, E ^a,b,c   Coutrot, A ^b   Carbon, C ^a   Collatz, E ^b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Laboratoires Astra France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ISEPAMICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029806579     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2848     Document Type: Article

References (25)

1. Blaser, J., B. B. Stone, M. C. Groner, and S. H. Zinner. 1987. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bacterial activity and emergence of resistance. Antimicrob. Agents Chemother. 31:1054-1060.
2. Brun-Buisson, C., P. Legrand, and A. Philippon. 1987. Transferable enzymatic resistance to third-generation cephalosporins during a nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii:302-306.
3. Bryan, L. E. 1984. Aminoglycoside resistance, p. 241-277. In L. E. Bryan (ed.). Antimicrobial drug resistance. Academic Press, Orlando, Fla.
4. Caron, F., L. Gutmann, A. Buré, B. Pangon, J. M. Vallois, A. Pechinot, and C. Carbon. 1990. Ceftriaxonc-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 β-lactamase. Antimicrob. Agents Chemother. 11:2070-2074.
5. Cleeland, R., and E. Grunberg. 1986. Laboratory evaluation of new antibiotics in vitro and in experimental animal infections, p. 537-578. In C. Lorian (ed.). Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore.
6. Contrepols, A., J. M. Vallois, J. J. Garaud, B. Pangon, J. Mohler, A. Meulemans, and C. Carbon. 1986. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia colt endocarditis. J. Antimicrob. Chemother. 17:227-237.
7. Davies, J., and D. I. Smith. 1978. Plasmid-determined resistance to antimicrobial agents. Annu. Rev. Microbiol. 32:469-518.
8. Dudek, J., D. W. Forman, and M. W. Fordice. 1982. Therapeutic drug monitoring by fluorescence polarization: performance of immunoassays for the aminoglycoside antibiotics gentamicin, tobramycin and amikacin. Clin. Chem. 28:1667-1669.
9. Fantin, B., and C. Carbon. 1992. In vivo antibiotic synergism: contribution of animal models. Antimicrob. Agents Chemother. 36:907-912.
10. Godfrey, A. M. 1985. Statistics in practice. Comparing the means of several groups. N. Engl. J. Med. 313:1450-1456.
11. Kabins, S. A., and C. Nathan. 1978. In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin. Antimicrob. Agents Chemother. 14:785-787.
12. Krogstad, D. J., and R. C. Moellering. 1986. Antimicrobial combinations, p. 537-578. In C. Lorian (ed.). Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore.
13. Mainardi, J. L., X. Y. Zhou, F. Goldstein, J. Mohler, K. Farinotti, L. Gutmann, and C. Carbon. 1994. Activity of isepamicin and selection of permeability mutants to β-lactams during aminoglycoside therapy at experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransterase 6′ modifying enzyme and a TEM-3 β-lactamase. J. Infect. Dis. 169:1318-1324.
14. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N. Y.
15. Miller, G. H., P. J. S. Chiu, and J. A. Waitz. 1978. Biological activity of Sch 21420, the 1-N-S-a-hydroxy-β-aminopropionyl derivative of gentamicin B. J. Antibiot. (Tokyo) Ser. A 31:688-696.
16. Miller, G. H., F. J. Sabatelli, R. S. Hare, and J. A. Waitz. 1980. Survey of aminoglycoside resistance patterns. Dev. Ind. Microbiol. 21:91-104.
17. Miller, G. H., F. J. Sabatelli, L. Naples, R. S. Hare, and K. J. Shaw. 1995. The most frequently occurring aminoglycoside resistance mechanisms. Combined results of surveys in eight regions of the world. J. Chemother. 7(Suppl. 2):17-30.
18. Perlman, B. B., and L. R. Freedman. 1971. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J. Biol. Med. 44:206-213.
19. Shaw, K. J., R. S. Hare, F. J. Sabatelli, M. Rizzo, C. A. Cramer, L. Naples, S. Kocsi, H. Munnayyer, O. Mann, G. H. Miller, L. Verbist, H. V. Landuyt, G. Glupczynski, M. Catalano, and M. Woloj. 1991. Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob. Agents Chemother. 35:2253-2261.
20. Shaw, K. J., P. N. Rather, R. S. Hare, and G. H. Miller. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the modifying enzymes. Microbiol. Rev. 57:139-163.
21. Shimizu, K., T. Kumada, W. C. Hsieh, H. Y. Chung, Y. Chong, R. S. Hare, G. H. Miller, F. J. Sabatelli, and J. Howard. 1985. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob. Agents Chemother. 28:282-288.
22. Sirot, J., C. Chanal, A. Petit, D. Sirot, R. Labia, and G. Gerbaud. 1988. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Rev. Infect. Dis. 10:850-859.
23. Thornsberry, C., A. L. Barry, R. N. Jones, C. N. Baker, R. E. Badal, and R. R. Packer. 1980. Comparison of in vitro activity of SCH 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. Antimicrob. Agents Chemother. 18:338-345.
24. Tran Van Nhieu, G., F. Bordon, and E. Collatz. 1992. Incidence of an aminoglycosidc 6′-N-acetyltransferase, ACC(6′)-Ib, in amikacin-resistant clinical isolates of gram-negative bacilli, as determined by DNA-DNA hybridisation and immunoblotting. J. Med. Microbiol. 36:83-88.
25. Tran Van Nhieu, G., and E. Collatz. 1987. Primary structure of an aminoglycoside 6′-N-acetyltransferase, AAC(6′)-4, fused in vivo with the signal peptide of the Tn3-encoded β-lactamase. J. Bacteriol. 169:5708-5714.